BD Advanced Patient Monitoring enhances BD’s smart connected care solutions. Credit: BD (Becton, Dickinson and Company) / PRNewswire.

BD (Becton, Dickinson and Company), a leading medical technology company, has announced the completion of its acquisition of Edwards Lifesciences‘ Critical Care product group.

The $4.2bn all-cash transaction, announced in June 2024, will see the Critical Care product group being renamed as BD Advanced Patient Monitoring.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

BD Advanced Patient Monitoring enhances BD’s smart connected care solutions with its portfolio of monitoring technologies, AI-enabled clinical decision tools, and a robust innovation pipeline. The technologies from BD Advanced Patient Monitoring are often used alongside the BD Alaris Infusion System in critical care settings such as operating rooms and intensive care units.

The integration of BD’s new monitoring and existing infusion platforms paves the way for future innovations in closed-loop haemodynamic monitoring and IV fluid and medication administration. This is made possible by integrating combined company data sets and interoperability capabilities.

The product line of BD Advanced Patient Monitoring includes the Swan Ganz pulmonary artery catheter, sensors, cuffs, tissue oximetry sensors, and monitors. These smart technologies utilise advanced data analytics, machine learning, and AI-based algorithms to aid clinicians in patient care decisions.

BD Advanced Patient Monitoring will be a distinct business unit within BD’s Medical segment, adhering to the company’s smart connected care strategy. The unit will continue to operate from Irvine, California.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Edwards’ former corporate vice president Katie Szyman has been appointed worldwide president of BD Advanced Patient Monitoring. She will report to Mike Garrison, executive vice president and president of the BD Medical segment.

The acquisition is expected to have a negligible effect on BD’s fiscal year 2024 guidance, as outlined in the 1 August third-quarter earnings news release.